Ongoing projects

7.133 M
MetEx+ "Next generation metabolomics and fluxomics, from population to single cells"
Coordinator: Fabien Jourdan
Nb of partners:  4
14.9 M

MetaboHub is a project funded by the "Infrastructure d'avenir" which propose a national platform in metabolomics and fluxomics.
Coordinator: Fabien Jourdan
Project code: ANR-11-INBS-0010
Nb of partners:  5
Research collaboration with L'Oréal
L'Oréal Paris se lance dans l'aventure retail en ouvrant sa boutique à Paris

Shared PhD (thèse CIFRE)
L'Oréal collaboration with toxiciology department of the company.
Coordinator: Fabien Jourdan, Olivier Perin
Nb of partners: 2

928 k€

New approaches to bridge the gap between genome-scale metabolic networks and untargeted metabolomics

Fabien Jourdan
Nb of partners: 4
ANR general grant number: ANR-19-CE45-0021
6.75 millon €
SAFFI Safe Food for Infants in China and the EU

Coordinator: Erwan Engel (INRAE)
Call: H2020
Image associée
300 k
Predictive toxicology approach for prioritizing the assessment of chemical agents

Coordinator: Fabien Jourdan
Nb of partners: 3
6.7 million
800 k)
Generation Of NoveL, Integrated and Internationally Harmonised Approaches for Testing Metabolism Disrupting Compounds.
Coordinator: Juliette Legler
Nb of partners: 15
Call: H2020
Project id: #825489
MDM2 and serine metabolism: New therapeutic targets for liposarcomas
631 k€

WP Leader
MDM2 and serine metabolism: New therapeutic targets for liposarcomas
The project aims at furthering our understanding of MDM2 metabolic functions in LPS and at investigating whether these functions can be targeted to design efficient anti-cancer therapies. Using complementary gene expression and metabolomic profiling approaches, we will extend our initial characterization of MDM2-associated metabolic functions, and use systems biology approaches and computational network modeling to understand the contribution of these metabolic networks in LPS development. We also wish to explore further a new concept in LPS pathogenesis, related to a potential metabolic cooperation between normal tissues/cells and LPS via serine biodisponibility. Finally, we will take advantage of a unique biobank and humanized mouse models (Patient-derived xenograft models) that we generated over the past years, to assess the clinical relevance of potential new biomarkers and new therapeutic strategies based on the pharmacological inhibition of MDM2 metabolic functions.
Coordinator: Laetitia Linares, INSERM (Montpellier)
Nb of partners: 3
Call: INCA "Biology and Basic Sciences for Cancer research"
Computational modeling of p53 metabolic functions


WP leader
 Computational modeling of p53 metabolic functions. We propose to develop an ambitious project aiming at developing the first computational model of the metabolic functions of the p53 tumor suppressor pathway and to use this model to further understand how deregulation of these metabolic networks contributes to cancer development.
Coordinator: Laurent Le Cam, INSERM (Montpellier)
Nb of partners: 3
Call: INCA "Biology and Basic Sciences for Cancer research"

Past projects


10 million
300 k)

A comprehensive and standardised e-infrastructure for analysing medical metabolic phenotype data. The PhenoMeNal2 project will develop and deploy an integrated, secure, permanent, on-demand service-driven, privacy-compliant and sustainable e-infrastructure for the processing, analysis and
information-mining of the massive amount of medical molecular phenotyping and genotyping data that will be generated by metabolomics applications now entering research and clinic.
Coordinator: Christophe Steinbeck, EBI (UK)
Nb of partners: 15
Call: H2020-EINFRA-1-2014 (Managing, preserving and computing with big research data)
Project id: 654241


Newplast: Contribution to the Human exposure assessment related to substitutes and derivates of Bisphenol A and the associated hazard characterisation.
Coordinator: Jean-Philippe Antignac
Nb of partners: 5

17 k

 MetabOlism FramewOrk. The aim is to build a generic web server based on javascript component. This will be applied to create web resources for projects developed in the INRA Human Nutrition Division.
Coordinators: Fabien Jourdan & Franck Giacomoni
Nb of partners: 3

  3.8 million
(254 k)

WP leader
 ParaMet is a Marie Curie Initial Training Network (ITN) funding 12 PhD Scholarships. The research of ParaMet will concentrate on genomic, metabolic and regulatory mechanisms of protozoan parasites, in multidisciplinary projects, identifying areas of parasite metabolism and key factors of host-parasite interactions that may be exploitable for new chemotherapies. Systems approaches involving mathematical modelling of metabolic and transcriptional processes will be central.
Coordinator: Sylke Muller (University of Glasgow)
Project identifier: FP7-PEOPLE-2011-ITN
Project number: 290080

Nb of partners: 12
 Merlion Workshop

25 k


 Developing Metabolomics Platform Technologies through Singapore-French Research Alliance: The workshop aims to encourage technical exchanges and catalyze the development of research collaboration in the field of metabolomics between Singapore and France. In addition, this workshop provides opportunities for the knowledge and technologies developed in Europe to be applied in the Asian context.
Coordinators: Domnique Rolin and Fabien Jourdan (France)
Ong, Choon Nam (National University of Singapore (Singapore)
Nb of partners: 2
 DID'IT Modélisation
14 k

Modélisation globale du métabolisme humain : des données métabolomiques à l'interprétation biologique: In the framework of DID'IT INRA Metaprogramme, we will organize a workshop on metabolomics data treatment from raw data to biological interpretation.
Coordinators: Estelle Pujos Guillot and Fabien Jourdan
Nb of partners: 2
10 k

 M-DIET: In the framework of DID'IT INRA Metaprogramme, the aim is to understand the network impact of diet changes based on metabolomics data.
Coordinator: Fabien Jourdan

Nb of partners: 1

362 k


Master funding
 NeoMeaTox aim is to determine in twoanimal models of colorectal cancer the individual and synergistic roles of model molecules of those family of compounds (HCA PhiP, the PAH benzo[a]pyrene and the secondary lipid oxidation product 4-hydroxynonenal), given in concentration related to realistic human dietary consumption. Those in vivo studies will be completed by in vitro studies on original cellular models of non cancerous colonocytes, bearing or not a mutation on the Apc gene, an early and frequent event in human colorectal cancer development.
Coordinator: Françoise Guéraud (INRA, TOXALIM)

Nb of partners:  3

390  k

 CONTREPERF stands for: Emerging perfluorinated contaminants: contribution to the human exposure assessment, to the study of their metabolism and to the characterisation of their toxicological impact.
Coordinator: Jean-Philippe Antignac

Nb of partners: 5